Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
Clinical trial NCT04838041 · RECRUITING
Trial details
- NCT number
- NCT04838041
- Sponsor
- Medical College of Wisconsin
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-11
- Primary completion
- 2028-06-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.